[1]
|
Zaidi, S.B.H. and Ali Khan, W. (2021) Is Pterygium Morphology Related to Loss of Corneal Endothelial Cells? A Cross-Sectional Study. Clinical Ophthalmology, 15, 1259-1266. https://doi.org/10.2147/OPTH.S296531
|
[2]
|
Zhao, D., Zhao, H., He, Y., et al. (2021) The Inhibitive Effects of Proteasome Inhibitor MG-132 on Pterygium Fibroblasts in vitro and the Potential Key Regulators Involved. Life Sciences, 270, Article ID: 119088.
https://doi.org/10.1016/j.lfs.2021.119088
|
[3]
|
Zhou, W.P., Zhu, Y.F., Zhang, B., et al. (2016) The Role of Ultravi-olet Radiation in the Pathogenesis of Pterygia (Review). Molecular Medicine Reports, 14, 3-15. https://doi.org/10.3892/mmr.2016.5223
|
[4]
|
Shahraki, T., Arabi, A. and Feizi, S. (2021) Pterygium: An Update on Pathophysiology, Clinical Features, and Management. Therapeutic Advances in Ophthalmology, Vol. 13. https://doi.org/10.1177/25158414211020152
|
[5]
|
Wanzeler, A.C.V., Duarte, B., de Andrade, V.D.M., et al. (2018) Impact of Conjunctival Autograft on Pterygium Treatment: Evaluation of Related Symptoms and Patients’ Satisfaction after Surgery. Clinical Ophthalmology, 12, 833-837. https://doi.org/10.2147/OPTH.S155631
|
[6]
|
Baheran, S.S., Alany, R.G., Schwikkard, S., et al. (2023) Pharmacological Treatment Strategies of Pterygium: Drugs, Biologics, and Novel Natural Products. Drug Discovery Today, 28, Article ID: 103416.
https://doi.org/10.1016/j.drudis.2022.103416
|
[7]
|
Martín-López, J., Pérez-Rico, C., Benito-Martínez, S., et al. (2021) The Role of the Stromal Extracellular Matrix in the Development of Pterygium Pathology: An Update. Journal of Clinical Medicine, 10, Article 5930.
https://doi.org/10.3390/jcm10245930
|
[8]
|
Elgouhary, S.M., Elmazar, H.F., Naguib, M.I., et al. (2020) Role of Oxidative Stress and Vascular Endothelial Growth Factor Expression in Pterygium Pathogenesis and Prevention of Pter-ygium Recurrence after Surgical Excision. International Ophthalmology, 40, 2593-2606. https://doi.org/10.1007/s10792-020-01440-2
|
[9]
|
Zavala, J., Hernandez-Camarena, J.C., Salvador-Gálvez, B., et al. (2018) Extracellular Matrix and Fibroblast Injection Produces Pterygium-Like Lesion in Rabbits. Biological Research, 51, Article No. 15.
https://doi.org/10.1186/s40659-018-0165-8
|
[10]
|
Tan, J., Vollmer-Conna, U., Tat, L., et al. (2019) Dry-Eye Disease in Recurrent Pterygium. Ophthalmic Research, 61, 199-203. https://doi.org/10.1159/000493544
|
[11]
|
He, S. and Wu, Z. (2022) Biomarkers in the Occurrence and Development of Pterygium. Ophthalmic Research, 65, 481-492. https://doi.org/10.1159/000523878
|
[12]
|
Watanabe, M., Tsugeno, Y., Sato, T., et al. (2023) TGF-β Isoforms Affect the Planar and Subepithelial Fibrogenesis of Human Conjunctival Fibroblasts in Different Manners. Biomedicines, 11, Article 2005.
https://doi.org/10.3390/biomedicines11072005
|
[13]
|
Casciano, F., Zauli, E., Busin, M., et al. (2023) State of the Art of Pharmacological Activators of p53 in Ocular Malignancies. Cancers, 15, Article 3593. https://doi.org/10.3390/cancers15143593
|
[14]
|
Yazar, S., Cuellar-Partida, G., Mcknight, C.M., et al. (2015) Genetic and Environmental Factors in Conjunctival UV Autofluorescence. JAMA Ophthalmology, 133, 406-412. https://doi.org/10.1001/jamaophthalmol.2014.5627
|
[15]
|
Anguria, P., Carmichael, T., Ntuli, S., et al. (2013) Chronic Inflammatory Cells and Damaged Limbal Cells in Pterygium. African Health Sciences, 13, 725-730. https://doi.org/10.4314/ahs.v13i3.29
|
[16]
|
Romano, V., Steger, B., Kovacova, A., et al. (2016) Further Evidence for Heredity of Pterygium. Ophthalmic Genetics, 37, 434-436. https://doi.org/10.3109/13816810.2015.1111911
|
[17]
|
Sámano-Hernández, L., Garfias, Y., González-Márquez, H., et al. (2023) Human Papilloma Virus Presence and Its Physical Status in Primary Pterygium. Heliyon, 9, e16189. https://doi.org/10.1016/j.heliyon.2023.e16189
|
[18]
|
Fernandes, M., Sangwan, V.S., Bansal, A.K., et al. (2005) Outcome of Pterygium Surgery: Analysis over 14 years. Eye, 19, 1182-1190. https://doi.org/10.1038/sj.eye.6701728
|
[19]
|
Jee, D., Park, M., Lee, H.J., et al. (2015) Comparison of Treatment with Preservative-Free Versus Preserved Sodium Hyaluronate 0.1% and Fluorometholone 0.1% Eyedrops after Cataract Surgery in Patients with Preexisting Dry-Eye Syndrome. Journal of Cataract and Refractive Surgery, 41, 756-763. https://doi.org/10.1016/j.jcrs.2014.11.034
|
[20]
|
Hwang, H.S., Cho, K.J., Rand, G., et al. (2018) Optimal Size of Pterygium Excision for Limbal Conjunctival Autograft Using Fibrin Glue in Primary Pterygia. BMC Ophthalmology, 18, Article No. 135.
https://doi.org/10.1186/s12886-018-0790-6
|
[21]
|
Bilge, A.D. (2018) Comparison of Conjunctival Autograft and Conjunctival Transposition Flap Techniques in Primary Pterygium Surgery. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society, 32, 110-113. https://doi.org/10.1016/j.sjopt.2017.11.002
|
[22]
|
Akbari, M. (2022) Update on Overview of Pterygium and Its Sur-gical Management. Journal of Population Therapeutics and Clinical Pharmacology, 29, e30-e45. https://doi.org/10.47750/jptcp.2022.968
|
[23]
|
Sabater-Cruz, N., Dotti-Boada, M., Rios, J., et al. (2021) Postopera-tive Treatment Compliance Rate and Complications with Two Different Protocols after Pterygium Excision and Conjunc-tival Autografting. European Journal of Ophthalmology, 31, 932-937. https://doi.org/10.1177/1120672120917335
|
[24]
|
Paganelli, B., Sahyoun, M. and Gabison, E. (2023) Conjunctival and Limbal Conjunctival Autograft vs. Amniotic Membrane Graft in Primary Pterygium Surgery: A 30-Year Compre-hensive Review. Ophthalmology and Therapy, 12, 1501-1517. https://doi.org/10.1007/s40123-023-00689-x
|
[25]
|
Özdemi,r M. (2008) Conjunctival Z-Plasty for Pterygium: Com-parison with Conjunctival Autografting. Electronic Journal of General Medicine, 5, 84-89. https://doi.org/10.29333/ejgm/82583
|
[26]
|
Young, A.L. and Kam, K.W. (2019) Pterygium: Surgical Techniques and Choices. Asia-Pacific Journal of Ophthalmology, 8, 422-423. https://doi.org/10.1097/APO.0000000000000269
|
[27]
|
Kaufman, S.C., Jacobs, D.S., Lee, W.B., et al. (2013) Op-tions and Adjuvants in Surgery for Pterygium: A Report by the American Academy of Ophthalmology. Ophthalmology, 120, 201-208.
https://doi.org/10.1016/j.ophtha.2012.06.066
|
[28]
|
Luanratanakorn, P., Ratanapakorn, T., Suwan-Apichon, O., et al. (2006) Randomised Controlled Study of Conjunctival Autograft versus Amniotic Membrane Graft in Pterygium Excision. The British Journal of Ophthalmology, 90, 1476-1480. https://doi.org/10.1136/bjo.2006.095018
|
[29]
|
Fakhry, M.A. (2011) The Use of Mitomycin C with Autologous Limbal-Conjunctival Autograft Transplantation for Management of Recurrent Pterygium. Clinical Ophthalmology, 5, 123-127.
https://doi.org/10.2147/OPTH.S16474
|
[30]
|
Mutlu, F.M., Sobaci, G., Tatar, T., et al. (1999) A Comparative Study of Recurrent Pterygium Surgery: Limbal Conjunctival Autograft Transplantation versus Mitomycin C with Conjunctival Flap. Ophthalmology, 106, 817-821.
https://doi.org/10.1016/S0161-6420(99)90172-0
|
[31]
|
Zhang, Q., Bao, N., Liang, K., et al. (2018) Adjuvant Use of Cyclosporine A in the Treatment of Primary Pterygium: A Systematic Review and Meta-Analysis. Cornea, 37, 1000-1007. https://doi.org/10.1097/ICO.0000000000001542
|
[32]
|
Mandal, A., Gote, V., Pal, D., et al. (2019) Oc-ular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease. Pharmaceutical Research, 36, Article No. 36.
https://doi.org/10.1007/s11095-018-2556-5
|
[33]
|
Zhai, L.Y., Zhang, X.R., Liu, H., et al. (2020) Observation of Topical Tacrolimus on High-Risk Penetrating Keratoplasty Patients: A Randomized Clinical Trial Study. Eye, 34, 1600-1607.
https://doi.org/10.1038/s41433-019-0717-3
|
[34]
|
Hacioğlu, D. and Erdöl, H. (2017) Developments and Current Approaches in the Treatment of Pterygium. International Ophthalmology, 37, 1073-1081. https://doi.org/10.1007/s10792-016-0358-5
|
[35]
|
Wu, H. and Chen, G. (1999) Cyclosporine A and Thiotepa in Prevention of Postoperative Recurrence of Pterygium. Yan Ke Xue Bao, 15, 91-92. (In Chinese)
|
[36]
|
Yu, J., Feng, J., Jin, T., et al. (2021) The Effect of a Novel Strategy in Treating Primary Pterygium: A Prospective Randomized Clinical Study. American Journal of Ophthalmology, 225, 108-116.
https://doi.org/10.1016/j.ajo.2021.01.001
|
[37]
|
Yin, M., Li, H., Zhang, Y., et al. (2019) Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium after the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study. Cornea, 38, 1239-1244.
https://doi.org/10.1097/ICO.0000000000001995
|
[38]
|
Razeghinejad, M.R. and Banifatemi, M. (2014) Subconjunc-tival Bevacizumab for Primary Pterygium Excision; A Randomized Clinical Trial. Journal of Ophthalmic & Vision Re-search, 9, 22-30.
|
[39]
|
Fallah, M.R., Khosravi, K., Hashemian, M.N., et al. (2010) Efficacy of Topical Bevacizumab for Inhibiting Growth of Impending Recurrent Pterygium. Current Eye Research, 35, 17-22. https://doi.org/10.3109/02713680903395273
|
[40]
|
Papathanassiou, M., Theodossiadis, P.G., Liarakos, V.S., et al. (2008) Inhibition of Corneal Neovascularization by Subconjunctival Bevacizumab in an Animal Model. American Jour-nal of Ophthalmology, 145, 424-431.
https://doi.org/10.1016/j.ajo.2007.11.003
|
[41]
|
Mansour, A.M. (2009) Treatment of Inflamed Pterygia or Residual Pterygial Bed. The British Journal of Ophthalmology, 93, 864-865. https://doi.org/10.1136/bjo.2008.155291
|
[42]
|
Kim, H.K., Choi, J.Y., Park, S.M., et al. (2017) Tyrosine Kinase In-hibitor, Vatalanib, Inhibits Proliferation and Migration of Human Pterygial Fibroblasts. Cornea, 36, 1116-1123. https://doi.org/10.1097/ICO.0000000000001268
|